Transmembrane glycoprotein FAS ligand (FASLG) is negatively targeted by micoRNA-21-5p, and high expression of micoRNA-21-5p induces cisplatin resistance in HCC cells by inhibiting FASLG expression levels [49]. Here, FASLG is linked to hepatocellular carcinoma.